Recombinant Anti-Cyclin E2 antibody [EP454Y] (ab40890)

Publishing research using ab40890? Please let us know so that we can cite the reference in this datasheet.

ab40890 has been referenced in 15 publications.

  • Tormo E  et al. The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors. Sci Rep 9:5316 (2019). PubMed: 30926829
  • Ke XX  et al. Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway. Oncol Rep 40:3313-3322 (2018). PubMed: 30542699
  • Song W  et al. PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer. Sci Rep 7:42319 (2017). PubMed: 28176879
  • Fischer MM  et al. WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Sci Adv 3:e1700090 (2017). PubMed: 28691093
  • Zhang L  et al. miRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer. Mol Med Rep 14:2077-84 (2016). PubMed: 27431942
  • Kong XY  et al. AKAP95 promotes cell cycle progression via interactions with cyclin E and low molecular weight cyclin E. Am J Transl Res 8:811-26 (2016). Human . PubMed: 27158371
  • Scharfmann R  et al. Development of a conditionally immortalized human pancreatic ß cell line. J Clin Invest 124:2087-98 (2014). WB ; Human . PubMed: 24667639
  • Lecona E  et al. Polycomb protein SCML2 regulates the cell cycle by binding and modulating CDK/CYCLIN/p21 complexes. PLoS Biol 11:e1001737 (2013). WB, IP ; Human . PubMed: 24358021
  • Pavelin J  et al. Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication. PLoS Pathog 9:e1003820 (2013). WB . PubMed: 24385903
  • Lee YF  et al. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast Cancer Res 14:R85 (2012). WB ; Human . PubMed: 22621393
  • Caldon CE  et al. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. Mol Cancer Ther 11:1488-99 (2012). IP ; Human . PubMed: 22564725
  • Mao L  et al. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression. Oncogene : (2011). PubMed: 22120721
  • Grey F  et al. A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs. PLoS Pathog 6:e1000967 (2010). WB ; Human . PubMed: 20585629
  • Santra MK  et al. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459:722-5 (2009). WB ; Human . PubMed: 19412162
  • Caldon CE  et al. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc. Mol Cell Biol 29:4623-39 (2009). PubMed: 19564413

For licensing inquiries, please contact

Sign up